About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01629771

Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India

According to the World Health Organization, lymphatic filariasis, a mosquito-borne parasitic disease, is the second leading cause of disability worldwide. Across 81 countries, approximately 120 millio...

Lead sponsor: Northwestern University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Northwestern University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Subjects with a clinical diagnosis of lymphatic filariasis
•Subjects over the age of 18 and able to give consent
•Subjects without a clinical diagnosis of lymphatic filariasis
•Subjects over the age of 18 and able to give consent

Exclusion Criteria

•Subjects on active treatment for lymphatic filariasis
•Subjects who are under the age of 18 or unable to give informed consent
•Subjects without a clinical diagnosis of lymphatic filariasis
•Subjects who are under the age of 18 or unable to give informed consent

Related studies

Not Yet RecruitingNA

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

NCT07506967 · Skin and Connective Tissue Diseases, Neglected Tropical Diseases, and more

Lymphatic Filariasis (LF) in Ivory Coast

NCT02974049 · Lymphatic Filariasis

Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia

NCT01905436 · Lymphatic Filariasis, Onchocerciasis, and more

COMPLETEDPhase 3

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka

NCT02929134 · Lymphedema, Lymphatic Filariasis, and more

Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG

NCT03268252 · Lymphatic Filariasis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 20, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment72

Start dateMay 2012

Last updatedMar 20, 2014

Condition

Lymphatic Filariasis

Locations shown

Northwestern University Department of Dermatology

Chicago, Illinois

Institute of Applied Dermatology

Kasaragod District, Kerala

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 20, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions